Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The International Journal of Tuberculosis and Lung Disease

• Publication date

  2016-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.5588/ijtld.15.0756PMID 26970158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic review and meta-analysis on the utility of Interferon-gamma release assays for the diagnosis of Mycobacterium tuberculosis infection in children: a 2013 update

  2014cited by this paper
• Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

  2014cited by this paper
• Performance of QuantiFERON-TB Gold and tuberculin skin test relative to subjects' risk of exposure to tuberculosis.

  2014cited by this paper
• Latent tuberculosis.

  2014cited by this paper
• Incremental value of T-SPOT.TB for diagnosis of active pulmonary tuberculosis in children in a high-burden setting: a multivariable analysis

  2013cited by this paper
• Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.

  2013cited by this paper
• Negative predictive value of TST and IGRA in anti-TNF treated patients

  2012cited by this paper
• Distinguishing Latent from Active Mycobacterium tuberculosis Infection Using Elispot Assays: Looking Beyond Interferon-gamma

  2012cited by this paper
• Latent tuberculosis infection in children: diagnostic approaches

  2012cited by this paper
• Dominant TNF-α+ Mycobacterium tuberculosis–specific CD4+ T cell responses discriminate between latent infection and active disease

  2011cited by this paper
• Are interferon-&ggr; release assays useful for diagnosing active tuberculosis in a high-burden setting?

  2011cited by this paper
• Use of tuberculosis interferon-gamma release assays (IGRAs) in low- and middle- income countries

  2011cited by this paper
• Interferon-Gamma Release Assays for the Diagnosis of Latent Tuberculosis Infection in HIV-Infected Individuals: A Systematic Review and Meta-Analysis

  2011cited by this paper
• Interferon-Gamma Release Assays for the Diagnosis of Active Tuberculosis in HIV-Infected Patients: A Systematic Review and Meta-Analysis

  2011cited by this paper
• Interferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysis.

  2011cited by this paper
• Immunodiagnosis of Tuberculosis: State of the Art

  2011cited by this paper
• Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects.

  2010cited by this paper
• Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells

  2010cited by this paper
• T-cell interferon-γ release assays for the rapid immunodiagnosis of tuberculosis: clinical utility in high-burden vs. low-burden settings

  2009cited by this paper
• Systematic Review: T-Cellbased Assays for the Diagnosis of Latent Tuberculosis Infection: An Update

  2008cited by this paper
• Tuberculosis in Africa: learning from pathogenesis for biomarker identification.

  2008cited by this paper
• Meta-analysis: New Tests for the Diagnosis of Latent Tuberculosis Infection: Areas of Uncertainty and Recommendations for ResearchMenzies D, Pai M, Comstock G (McGill Univ, Montreal; Johns Hopkins Univ, Baltimore, Md) Ann Intern Med 146:340–354, 2007§

  2008cited by this paper
• Use of an interferon-gamma release assay to diagnose latent tuberculosis infection in foreign-born patients.

  2008cited by this paper
• Diagnostic usefulness of a T-cell based assay for extrapulmonary tuberculosis.

  2007cited by this paper
• Quantitative scoring of an interferon-γ assay for differentiating active from latent tuberculosis

  2007cited by this paper
• CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease.

  2007cited by this paper
• Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)‐infected individuals enrolled with suspected active tuberculosis: a pilot study

  2007cited by this paper
• Interferon-gamma release assays: what is their role in the diagnosis of active tuberculosis?

  2007cited by this paper
• Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis.

  2007cited by this paper
• Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review.

  2004cited by this paper
• Foreign-born patients.

  1985cited by this paper

• Characteristics of subclinical pulmonary tuberculosis compared to active pulmonary tuberculosis: A retrospective cohort study

  2025cites this paper
• Advancements in Tuberculosis Diagnostics: An Update.

  2025cites this paper
• Differences in PPD- and mitogen-induced T-cell activation marker expression characterize immunopathology in acute tuberculosis patients

  2024influential citation
• The predictive value of TNF family for pulmonary tuberculosis: a pooled causal effect analysis of multiple datasets

  2024cites this paper
• Immunopathology in human pulmonary tuberculosis: Inflammatory changes in the plasma milieu and impaired host immune cell functions

  2024cites this paper
• Using immune clusters for classifying Mycobacterium tuberculosis infection.

  2024cites this paper
• T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis

  2023cites this paper
• A predictive model for early clinical diagnosis of spinal tuberculosis based on conventional laboratory indices: A multicenter real-world study

  2023cites this paper
• Impaired T-cell response to phytohemagglutinin (PHA) in tuberculosis patients is associated with high IL-6 plasma levels and normalizes early during anti-mycobacterial treatment

  2023influential citation
• Convolutional neural network based on T-SPOT.TB assay promoting the discrimination between active tuberculosis and latent tuberculosis infection.

  2023cites this paper
• Using TBAg/PHA Ratio for Monitoring TB Treatment: A Prospective Multicenter Study

  2022cites this paper
• Review and Updates on the Diagnosis of Tuberculosis

  2022cites this paper
• Tuberculosis-Specific Antigen/Phytohemagglutinin Ratio Combined With GeneXpert MTB/RIF for Early Diagnosis of Spinal Tuberculosis: A Prospective Cohort Study

  2022cites this paper
• A scoring system developed from a nomogram to differentiate active pulmonary tuberculosis from inactive pulmonary tuberculosis

  2022influential citation
• Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis

  2021cites this paper
• Harnessing Big Data to Optimize an Algorithm for Rapid Diagnosis of Pulmonary Tuberculosis in a Real-World Setting

  2021cites this paper
• Lymphocyte Non-Specific Function Detection Facilitating the Stratification of Mycobacterium tuberculosis Infection

  2021cites this paper
• Comparison of LAMP, GeneXpert, Mycobacterial Culture, Smear Microscopy, TSPOT.TB, TBAg/PHA Ratio for Diagnosis of Pulmonary Tuberculosis

  2021cites this paper
• Combination of HLA-DR on Mycobacterium tuberculosis-Specific Cells and Tuberculosis Antigen/Phytohemagglutinin Ratio for Discriminating Active Tuberculosis From Latent Tuberculosis Infection

  2021cites this paper
• Diagnostic Model for Discrimination Between Tuberculous Meningitis and Bacterial Meningitis

  2021cites this paper
• Combination of Xpert MTB/RIF and TBAg/PHA Ratio for Prompt Diagnosis of Active Tuberculosis: A Two-Center Prospective Cohort Study

  2020cites this paper
• The TBAg/PHA ratio in T-SPOT.TB assay has high prospective value in the diagnosis of active tuberculosis: a multicenter study in China

  2020cites this paper
• Combination of prealbumin and tuberculosis‐specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection

  2020cites this paper
• Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan.

  2020cites this paper
• Higher T-SPOT.TB Threshold May Aid in Diagnosing Active Tuberculosis?: A Real-world Clinical Practice in a General Hospital.

  2020cites this paper
• Combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.

  2020cites this paper
• Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.

  2020cites this paper
• End TB Strategy: Time to Move on From the Skin Test to the Interferon-γ Release Assays.

  2019cites this paper
• Hepcidin exerts a negative immunological effect in pulmonary tuberculosis without HIV co-infection, prolonging the time to culture negative.

  2019cites this paper
• Diagnostic Performance of a 5-Marker Predictive Model for Differential Diagnosis Between Intestinal Tuberculosis and Crohn's Disease.

  2018cites this paper
• Can we predict tuberculosis cure? What tools are available?

  2018cites this paper
• The Use of TB-Specific Antigen/Phytohemagglutinin Ratio for Diagnosis and Treatment Monitoring of Extrapulmonary Tuberculosis

  2018cites this paper
• Application of ImmunoScore Model for the Differentiation between Active Tuberculosis and Latent Tuberculosis Infection as Well as Monitoring Anti-tuberculosis Therapy

  2017cites this paper
• The performance of the TBAg/PHA ratio in the diagnosis of active TB disease in immunocompromised patients.

  2017cites this paper
• T-SPOT.TB 试验中 TBAg/PHA

  year unknowncites this paper